Logo image of CVRX

CVRX INC (CVRX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CVRX - US1266381052 - Common Stock

7.82 USD
-0.21 (-2.62%)
Last: 12/22/2025, 8:00:00 PM
Fundamental Rating

2

Overall CVRX gets a fundamental rating of 2 out of 10. We evaluated CVRX against 184 industry peers in the Health Care Equipment & Supplies industry. CVRX may be in some trouble as it scores bad on both profitability and health. CVRX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CVRX has reported negative net income.
In the past year CVRX has reported a negative cash flow from operations.
In the past 5 years CVRX always reported negative net income.
In the past 5 years CVRX always reported negative operating cash flow.
CVRX Yearly Net Income VS EBIT VS OCF VS FCFCVRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

The Return On Assets of CVRX (-46.73%) is worse than 64.67% of its industry peers.
CVRX's Return On Equity of -108.26% is on the low side compared to the rest of the industry. CVRX is outperformed by 62.50% of its industry peers.
Industry RankSector Rank
ROA -46.73%
ROE -108.26%
ROIC N/A
ROA(3y)-37.96%
ROA(5y)-32.85%
ROE(3y)-58.86%
ROE(5y)-49.03%
ROIC(3y)N/A
ROIC(5y)N/A
CVRX Yearly ROA, ROE, ROICCVRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K

1.3 Margins

The Gross Margin of CVRX (84.49%) is better than 92.93% of its industry peers.
CVRX's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for CVRX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 84.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.13%
GM growth 5Y2.79%
CVRX Yearly Profit, Operating, Gross MarginsCVRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

3

2. Health

2.1 Basic Checks

CVRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
CVRX has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CVRX has more shares outstanding
Compared to 1 year ago, CVRX has a worse debt to assets ratio.
CVRX Yearly Shares OutstandingCVRX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CVRX Yearly Total Debt VS Total AssetsCVRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of -5.23, we must say that CVRX is in the distress zone and has some risk of bankruptcy.
CVRX has a worse Altman-Z score (-5.23) than 71.74% of its industry peers.
CVRX has a Debt/Equity ratio of 1.03. This is a high value indicating a heavy dependency on external financing.
CVRX has a worse Debt to Equity ratio (1.03) than 75.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF N/A
Altman-Z -5.23
ROIC/WACCN/A
WACC8.56%
CVRX Yearly LT Debt VS Equity VS FCFCVRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

CVRX has a Current Ratio of 9.62. This indicates that CVRX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of CVRX (9.62) is better than 91.85% of its industry peers.
A Quick Ratio of 8.60 indicates that CVRX has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 8.60, CVRX belongs to the best of the industry, outperforming 90.76% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 9.62
Quick Ratio 8.6
CVRX Yearly Current Assets VS Current LiabilitesCVRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 25.19% over the past year.
CVRX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.44%.
The Revenue has been growing by 52.30% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)25.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.04%
Revenue 1Y (TTM)18.44%
Revenue growth 3Y57.85%
Revenue growth 5Y52.3%
Sales Q2Q%9.85%

3.2 Future

CVRX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.71% yearly.
Based on estimates for the next years, CVRX will show a quite strong growth in Revenue. The Revenue will grow by 19.45% on average per year.
EPS Next Y22.86%
EPS Next 2Y13%
EPS Next 3Y11.62%
EPS Next 5Y8.71%
Revenue Next Year10.14%
Revenue Next 2Y12.88%
Revenue Next 3Y15.64%
Revenue Next 5Y19.45%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CVRX Yearly Revenue VS EstimatesCVRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20M 40M 60M 80M 100M
CVRX Yearly EPS VS EstimatesCVRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 -5 -10 -15 -20

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CVRX. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CVRX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CVRX Price Earnings VS Forward Price EarningsCVRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CVRX Per share dataCVRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13%
EPS Next 3Y11.62%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CVRX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

CVRX INC

NASDAQ:CVRX (12/22/2025, 8:00:00 PM)

7.82

-0.21 (-2.62%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-02 2026-02-02/amc
Inst Owners60.33%
Inst Owner Change-3.81%
Ins Owners4.32%
Ins Owner Change0.67%
Market Cap204.96M
Revenue(TTM)55.97M
Net Income(TTM)-52.02M
Analysts80
Price Target11.73 (50%)
Short Float %6.25%
Short Ratio6.99
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.64%
Min EPS beat(2)-7.47%
Max EPS beat(2)4.2%
EPS beat(4)2
Avg EPS beat(4)-1.64%
Min EPS beat(4)-12.12%
Max EPS beat(4)8.82%
EPS beat(8)3
Avg EPS beat(8)-13.78%
EPS beat(12)7
Avg EPS beat(12)-5.22%
EPS beat(16)10
Avg EPS beat(16)-3.7%
Revenue beat(2)2
Avg Revenue beat(2)1.24%
Min Revenue beat(2)0.76%
Max Revenue beat(2)1.73%
Revenue beat(4)2
Avg Revenue beat(4)-1.79%
Min Revenue beat(4)-9.51%
Max Revenue beat(4)1.73%
Revenue beat(8)2
Avg Revenue beat(8)-2.21%
Revenue beat(12)6
Avg Revenue beat(12)0.45%
Revenue beat(16)9
Avg Revenue beat(16)0.97%
PT rev (1m)-0.86%
PT rev (3m)-0.86%
EPS NQ rev (1m)0.32%
EPS NQ rev (3m)-2.03%
EPS NY rev (1m)-0.21%
EPS NY rev (3m)-0.21%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)-1.74%
Revenue NY rev (1m)0.15%
Revenue NY rev (3m)0.15%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.66
P/FCF N/A
P/OCF N/A
P/B 4.27
P/tB 4.27
EV/EBITDA N/A
EPS(TTM)-2.02
EYN/A
EPS(NY)-1.95
Fwd EYN/A
FCF(TTM)-1.49
FCFYN/A
OCF(TTM)-1.47
OCFYN/A
SpS2.14
BVpS1.83
TBVpS1.83
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -46.73%
ROE -108.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 84.49%
FCFM N/A
ROA(3y)-37.96%
ROA(5y)-32.85%
ROE(3y)-58.86%
ROE(5y)-49.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.13%
GM growth 5Y2.79%
F-Score3
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 75.3%
Cap/Sales 1.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.62
Quick Ratio 8.6
Altman-Z -5.23
F-Score3
WACC8.56%
ROIC/WACCN/A
Cap/Depr(3y)167.13%
Cap/Depr(5y)316.6%
Cap/Sales(3y)2.41%
Cap/Sales(5y)4.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.04%
EPS Next Y22.86%
EPS Next 2Y13%
EPS Next 3Y11.62%
EPS Next 5Y8.71%
Revenue 1Y (TTM)18.44%
Revenue growth 3Y57.85%
Revenue growth 5Y52.3%
Sales Q2Q%9.85%
Revenue Next Year10.14%
Revenue Next 2Y12.88%
Revenue Next 3Y15.64%
Revenue Next 5Y19.45%
EBIT growth 1Y14.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year21.03%
EBIT Next 3Y8.15%
EBIT Next 5Y9.76%
FCF growth 1Y8.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.57%
OCF growth 3YN/A
OCF growth 5YN/A

CVRX INC / CVRX FAQ

Can you provide the ChartMill fundamental rating for CVRX INC?

ChartMill assigns a fundamental rating of 2 / 10 to CVRX.


What is the valuation status of CVRX INC (CVRX) stock?

ChartMill assigns a valuation rating of 0 / 10 to CVRX INC (CVRX). This can be considered as Overvalued.


What is the profitability of CVRX stock?

CVRX INC (CVRX) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for CVRX stock?

The Earnings per Share (EPS) of CVRX INC (CVRX) is expected to grow by 22.86% in the next year.